NCT05732350View on ClinicalTrials.gov

Exploratory Drug Interaction Study Between SMIs and DOACs

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

October 1, 2023

Study Completion Date

February 29, 2024

Conditions
Solid TumorCancer, Lung
Trial Locations (2)

6500HB

Radboud UMC, Nijmegen

6202AZ

Maastricht UMC, Maastricht

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

Maastricht University Medical Center

OTHER

NCT05732350 - Exploratory Drug Interaction Study Between SMIs and DOACs | Biotech Hunter | Biotech Hunter